AMPKα1 Deficiency in Astrocytes from a Rat Model of ALS Is Associated with an Altered Metabolic Resilience

Biomolecules. 2023 Jul 28;13(8):1183. doi: 10.3390/biom13081183.

Abstract

Alterations in the activity of the regulator of cell metabolism AMP-activated protein kinase (AMPK) have been reported in motor neurons from patients and animal models of amyotrophic lateral sclerosis (ALS). Considering the key role played by astrocytes in modulating energy metabolism in the nervous system and their compromised support towards neurons in ALS, we examined whether a putative alteration in AMPK expression/activity impacted astrocytic functions such as their metabolic plasticity and glutamate handling capacity. We found a reduced expression of AMPK mRNA in primary cultures of astrocytes derived from transgenic rats carrying an ALS-associated mutated superoxide dismutase (hSOD1G93A). The activation of AMPK after glucose deprivation was reduced in hSOD1G93A astrocytes compared to non-transgenic. This was accompanied by a lower increase in ATP levels and increased vulnerability to this insult, although the ATP production rate did not differ between the two cell types. Furthermore, soliciting the activity of glutamate transporters was found to induce similar AMPK activity in these cells. However, manipulation of AMPK activity did not influence glutamate transport. Together, these results suggest that the altered AMPK responsiveness in ALS might be context dependent and may compromise the metabolic adaptation of astrocytes in response to specific cellular stress.

Keywords: AMPK; ATP; glutamate transport; metabolic stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases
  • Adenosine Triphosphate
  • Amyotrophic Lateral Sclerosis* / genetics
  • Animals
  • Astrocytes
  • Glutamic Acid
  • Motor Neurons
  • Rats
  • Superoxide Dismutase-1 / genetics

Substances

  • AMP-Activated Protein Kinases
  • Glutamic Acid
  • Superoxide Dismutase-1
  • Adenosine Triphosphate

Grants and funding

This research was funded by the Association Belge contre les Maladies neuro-Musculaires (ABMM), grant number 2021; the Fonds Spéciaux de Recherche from the Université catholique de Louvain (UCLouvain); the Vrije Universiteit Brussel (OZR); and Fonds Wetenschappelijk Onderzoek Vlaanderen (FWO, I001420N to A.M. for medium-scale infrastructure; 12B3223N postdoctoral fellowship G.A.).